Anavex Life Sciences Corp (AVXL)
Operating Income Growth
54.84%
Quarterly · Period ending:
AVXL Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported54.84%period ending
Latest reported54.84%period ending
AVXL Quarterly Operating Income YoY % (-129.55% → 54.84%)
Year-over-year change
High-resolution chart · PNG
AVXL operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| 54.8447% | |
| 48.1819% | |
| 50.103% | |
| 24.3583% | |
| 0.9861% | |
| 0.8793% | |
| -19.4586% | |
| -13.3085% | |
| -7.9225% | |
| 11.0359% | |
| 25.9197% | |
| 17.2192% | |
| -8.6067% | |
| -23.1798% | |
| -31.0116% | |
| -24.749% | |
| -9.7165% | |
| -28.802% | |
| -24.7677% | |
| -63.1859% | |
| -40.0778% | |
| -16.1793% | |
| -23.2163% | |
| -19.7183% | |
| -14.6241% | |
| 4.5535% | |
| -3.0649% | |
| -7.8565% | |
| -55.6565% | |
| -70.3571% | |
| -80.8109% | |
| -12.3001% | |
| -24.9529% | |
| -31.7964% | |
| -30.5971% | |
| 21.0162% | |
| -61.9021% | |
| -66.8268% | |
| 20.1132% | |
| -65.2563% | |
| -48.444% | |
| -150.867% | |
| -408.9397% | |
| -520.4163% | |
| -51.4728% | |
| 15.9453% | |
| -148.9206% | |
| 56.3845% | |
| -692.8379% | |
| -703.3663% | |
| 25.4634% | |
| -126.4505% | |
| 81.9081% | |
| 84.0043% | |
| 81.021% | |
| 47.2232% | |
| 57.3947% | |
| 59.164% | |
| -59.8528% | |
| 37.5471% | |
| -25.4476% | |
| -28.2331% | |
| -55.5861% | |
| -9.0414% | |
| -3.6027% | |
| -96.845% | |
| 2.9481% | |
| 23.1429% | |
| 5.9756% | |
| -14.7672% | |
| 8.3214% | |
| -105.4312% | |
| -423.3342% | |
| -297.985% | |
| -7,915.4307% | |
| -19,417.0744% | |
| -4,399.4542% | |
| -3,521.9528% | |
| -31.1683% | |
| 85.9983% | |
| 87.5706% | |
| 89.8026% | |
| -129.551% |